Skip to content

Use of a new method of vasopressin injection compared to placebo in Hysteroscopic myomectomy. A prospective randomized double-blind controlled study

Use of a new method of vasopressin injection compared to placebo in Hysteroscopic myomectomy. A prospective randomized double-blind controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001784
Enrollment
Unknown
Registered
2011-12-12
Start date
2011-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroid

Interventions

Two groups:Vasopressin vs placebo, At the time of surgery only

Sponsors

North District Hospital, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 56 Years

Inclusion criteria

Inclusion criteria: Premenopausal women with symptomatic submucous fibroid will be recruited in the study. The diagnosis of submucous fibroid will be made by transvaginal ultrasound and diagnostic hysteroscopy. The size of the submucous fibroid will be measured by ultrasound. Hysteroscopic myomectomy will be performed for fibroids less than 5cm in size. The type of submucous fibroid will be determined by ultrasound and hysteroscopy using the Wamsteker classification(13).

Exclusion criteria

Exclusion criteria: Menopausal women, patients with endometrial premalignant or malignant pathologies, patients who require endometrial ablation, or on anticoagulant therapy, patients with cardiovascular diseases, migraine, asthma, heart failure, epilepsy and patients unwilling to participate will be excluded from the study. Women<18 years old will not be recruited.

Design outcomes

Primary

MeasureTime frame
Surgical time: cervical dilatation/myomectomy/poly;Fluid difference, intravasation of distending fluid;

Secondary

MeasureTime frame
Intraoperative blood loss;Drop in hemoglobin level;Complete excision;Intraoperative complication;Postoperative complication and Length of hospital stay;

Countries

China

Contacts

Public ContactDr. Alyssa Sze Wai Wong
alyssawong@cuhk.edu.hk+852 26838404

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026